Literature DB >> 12777264

National trends in the treatment of attention deficit hyperactivity disorder.

Mark Olfson1, Marc J Gameroff, Steven C Marcus, Peter S Jensen.   

Abstract

OBJECTIVE: Nationally representative descriptive data were presented regarding recent trends in the outpatient treatment of attention deficit hyperactivity disorder (ADHD) in children.
METHOD: Service use data were analyzed in children ages 3 to 18 years from two nationally representative surveys of the U.S. general population, the 1987 National Medical Expenditure Survey, and the 1997 Medical Expenditure Panel Survey. Trends in the rates of treatment for ADHD were presented by age, gender, race, family income, and health insurance status. Trends in ADHD treatment were also determined by annual numbers of visits, use of pharmacotherapies, and types of health care professionals.
RESULTS: The rate of outpatient treatment for ADHD increased from 0.9 per 100 children in 1987 to 3.4 per 100 children in 1997. Significant increases in the rates of treatment for ADHD were evident across nearly all sociodemographic groups, with the largest increases among children from poor, near-poor, and low-income families and children ages 12 to 18. Among children who received treatment for ADHD, there was a significant decrease in the number of treatment visits but an increase in the number of stimulant prescriptions between 1987 and 1997.
CONCLUSIONS: During the decade, there was a marked and broad expansion in access to treatment of children with ADHD but a decline in intensity of treatment, as measured by number of visits. These changes occurred during a period of expanding access to special education services, growth of managed behavioral healthcare, and increased public acceptance of effective psychotropic medications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777264     DOI: 10.1176/appi.ajp.160.6.1071

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  74 in total

1.  Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010.

Authors:  Craig F Garfield; E Ray Dorsey; Shu Zhu; Haiden A Huskamp; Rena Conti; Stacie B Dusetzina; Ashley Higashi; James M Perrin; Rachel Kornfield; G Caleb Alexander
Journal:  Acad Pediatr       Date:  2012-02-10       Impact factor: 3.107

2.  Polypharmacy in attention deficit hyperactivity disorder treatment: current status, challenges and next steps.

Authors:  Regina Bussing; Almut G Winterstein
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

3.  The dopamine dilemma: using stimulants and antipsychotics concurrently.

Authors:  Jason Yanofski
Journal:  Psychiatry (Edgmont)       Date:  2010-06

4.  Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005.

Authors:  Catherine A Fullerton; Arnold M Epstein; Richard G Frank; Sharon-Lise T Normand; Christina X Fu; Thomas G McGuire
Journal:  Psychiatr Serv       Date:  2012-02-01       Impact factor: 3.084

Review 5.  Parental preferences and goals regarding ADHD treatment.

Authors:  Alexander G Fiks; Stephanie Mayne; Elena Debartolo; Thomas J Power; James P Guevara
Journal:  Pediatrics       Date:  2013-09-02       Impact factor: 7.124

6.  Medical and nonmedical use of prescription drugs among secondary school students.

Authors:  Sean Esteban McCabe; Carol J Boyd; Amy Young
Journal:  J Adolesc Health       Date:  2006-10-05       Impact factor: 5.012

7.  Disparities in the reporting and treatment of health conditions in children: an analysis of the Medical Expenditure Panel Survey.

Authors:  James P Guevara; David S Mandell; Anthony L Rostain; Huaqing Zhao; Trevor R Hadley
Journal:  Health Serv Res       Date:  2006-04       Impact factor: 3.402

8.  Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice.

Authors:  Marjelo A Mines; Eleonore Beurel; Richard S Jope
Journal:  Eur J Pharmacol       Date:  2012-10-23       Impact factor: 4.432

9.  Racial and Ethnic Differences in ADHD Treatment Quality Among Medicaid-Enrolled Youth.

Authors:  Janet R Cummings; Xu Ji; Lindsay Allen; Cathy Lally; Benjamin G Druss
Journal:  Pediatrics       Date:  2017-05-16       Impact factor: 7.124

10.  Attitudes about stimulant medication for attention-deficit/hyperactivity disorder among African American families in an inner city community.

Authors:  Susan dosReis; Arlene Butz; Paul H Lipkin; Julia S Anixt; Courtney L Weiner; Robin Chernoff
Journal:  J Behav Health Serv Res       Date:  2006-10       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.